Načítá se...
Metabolic vulnerability of KRAS-driven cancer cells
Interfering with anaplerotic utilization of glutamine (Gln) was recently reported to sensitize KRAS-driven cancer cells to the cytotoxic effects of capecitabine and paclitaxel. This effect was due to bypass of a Gln-dependent G(1) cell cycle checkpoint in these cells. This study highlights therapeut...
Uloženo v:
| Vydáno v: | Mol Cell Oncol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4655600/ https://ncbi.nlm.nih.gov/pubmed/26609545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/23723548.2014.963445 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|